Shizuoka, Japan

Ryouhei Ueno

This inventor holds 1 USPTO granted patent. Top assignees: Ihara Chemical Industry Co., Ltd., Kumiai Chemical Industry Co., Ltd.. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryouhei Ueno: Innovator in Pyridine Compounds

Introduction

Ryouhei Ueno is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of chemistry, particularly in the development of pyridine compounds that are useful as pesticides. His innovative work has led to the granting of a patent, showcasing his expertise and dedication to advancing agricultural science.

Latest Patents

Ryouhei Ueno holds a patent for pyridine compounds, which are recognized for their utility in pesticide applications. This patent highlights his ability to create effective solutions for pest control, contributing to the agricultural industry.

Career Highlights

Throughout his career, Ryouhei Ueno has worked with prominent companies such as Kumiai Chemical Industry Co., Ltd. and Ihara Chemical Industry Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to various projects that enhance agricultural productivity.

Collaborations

Ryouhei Ueno has collaborated with talented individuals in his field, including Tomonori Shimazu and Mieko Kawashima. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Ryouhei Ueno's contributions to the field of chemistry, particularly through his patent for pyridine compounds, demonstrate his commitment to innovation in agriculture. His work continues to impact the industry positively, showcasing the importance of inventive minds in solving real-world challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…